Associated Papers
Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson's Disease for Drug Identification.
Kouroupi G et al.
International Journal of Molecular Sciences, 2020
Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population.
Nuytemans K et al.
Human Mutation, 2009
Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
Klein C et al.
The Lancet. Neurology, 2007
Progress in familial Parkinson's disease.
Mizuno Y et al.
Journal of Neural Transmission. Supplementum, 2006
Parkin genetics: one model for Parkinson's disease.
Mata IF et al.
Human Molecular Genetics, 2004
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects.
Periquet M et al.
American Journal of Human Genetics, 2001
Familial Parkinson's disease. Alpha-synuclein and parkin.
Mizuno Y et al.
Advances in Neurology, 2001
Progress in the clinical and molecular genetics of familial parkinsonism.
Kitada T et al.
Neurogenetics, 2000
A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
Abbas N et al.
Human Molecular Genetics, 1999
Select a paper to view details